spacer
home > ict > spring 2018 > the engagement equation
PUBLICATIONS
International Clinical Trials

The Engagement Equation

Patient engagement not only impacts study timelines and budgets, but it is a key driver for clinical trial success. As the marketplace has become more dynamic with the introduction of new tools and technologies, engagement pathways have expanded. As a result, a corresponding shift in mindset needs to occur. Engagement must be recognised as starting well before the patientís first visit, at the time of study awareness. Recruitment and retention must also be recognised as unified under the umbrella of engagement, rather than as separate concepts. Finally, a shift is needed from a patient-centric mindset to a study-centric mindset, where emphasis moves to the study community and the tools that can be utilised to maximise study efficiency.

Being Study-Centric


Identifying the problem, defining success, and building solutions are the cornerstones for study centricity. To be effective, one needs to identify potential roadblocks that may impact study efficiency. They may be protocolbased, such as the number or frequency of study visits, impacting patients and sites alike, or they may impact the entire study community, such as the overall length of the study. However, once identified, defining success with key performance indicators (KPIs) is important. In the event of a burdensome visit schedule, limiting the number of schedule changes could be considered. Once the KPI has been determined, one is then in a position to build the solution. In this case, perhaps it is a travel programme designed to remove burden, supporting patients getting to and from study appointments while also offering a reimbursement option.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Aaron Fleishman at BBK Worldwide oversees strategic consultation and product development and provides insights into patient recruitment technology development trends. He is responsible for building strategic partnerships, developing innovative products for patient-centric clinical trials, and consulting the pharma industry on implementing new innovative ideas.

Sarah Mandracchia at BBK Worldwide has more than a decade of experience translating complex market research and patient insights into effective media strategies for global patient recruitment campaigns. Sarah is responsible for upholding strategic direction and imperatives throughout the lifecycle of clinical trial programmes.

spacer
Aaron Fleishman
spacer
spacer
spacer
Sarah Mandracchia
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

e-tools enhance clinical trial performance

e-novex

In todayís ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: itís where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on todayís hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement